Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.920
+0.120 (2.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $187.03 million as of December 20, 2024. Its market cap has decreased by -30.33% in one year.
Market Cap
187.03M
Enterprise Value
121.94M
1-Year Change
-30.33%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $187.03M, a decrease of -5.28%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 187.03M | -42.69% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 185.59M |
| Myomo | 184.20M |
| Quantum-Si incorporated | 184.10M |
| Organigram Holdings | 183.68M |
| Genfit | 181.18M |
| Inozyme Pharma | 180.51M |
| Accuray | 180.01M |
| Lyell Immunopharma | 178.98M |